In Veritas Medical Performance

IVMEDelisted Stock  USD 0.0007  0.00  0.00%   
The company owns a Beta (Systematic Risk) of -0.0691, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning In Veritas are expected to decrease at a much lower rate. During the bear market, In Veritas is likely to outperform the market. In Veritas Medical at this time owns a risk of 0.0%. Please check out In Veritas Medical variance, as well as the relationship between the skewness and day typical price , to decide if In Veritas Medical will be following its current price history.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days In Veritas Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, In Veritas is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
  

In Veritas Relative Risk vs. Return Landscape

If you would invest  0.07  in In Veritas Medical on December 4, 2025 and sell it today you would earn a total of  0.00  from holding In Veritas Medical or generate 0.0% return on investment over 90 days. In Veritas Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than IVME, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

In Veritas Target Price Odds to finish over Current Price

The tendency of IVME Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0007 90 days 0.0007 
about 73.49
Based on a normal probability distribution, the odds of In Veritas to move above the current price in 90 days from now is about 73.49 (This In Veritas Medical probability density function shows the probability of IVME Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days In Veritas Medical has a beta of -0.0691. This usually indicates as returns on the benchmark increase, returns on holding In Veritas are expected to decrease at a much lower rate. During a bear market, however, In Veritas Medical is likely to outperform the market. Additionally In Veritas Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   In Veritas Price Density   
       Price  

Predictive Modules for In Veritas

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as In Veritas Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00090.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00070.00
Details
Naive
Forecast
LowNextHigh
0.050.050.05
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00070.00070.0007
Details

In Veritas Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. In Veritas is not an exception. The market had few large corrections towards the In Veritas' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold In Veritas Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of In Veritas within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.0039
β
Beta against Dow Jones-0.07
σ
Overall volatility
0.13
Ir
Information ratio -0.0025

In Veritas Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of In Veritas for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for In Veritas Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
In Veritas Medical is not yet fully synchronised with the market data
In Veritas Medical has some characteristics of a very speculative penny stock
In Veritas Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0.
In Veritas generates negative cash flow from operations

In Veritas Fundamentals Growth

IVME Stock prices reflect investors' perceptions of the future prospects and financial health of In Veritas, and In Veritas fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IVME Stock performance.

About In Veritas Performance

By analyzing In Veritas' fundamental ratios, stakeholders can gain valuable insights into In Veritas' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if In Veritas has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if In Veritas has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with near-patient testing applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. IN Veritas operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 7 people.

Things to note about In Veritas Medical performance evaluation

Checking the ongoing alerts about In Veritas for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for In Veritas Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
In Veritas Medical is not yet fully synchronised with the market data
In Veritas Medical has some characteristics of a very speculative penny stock
In Veritas Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0.
In Veritas generates negative cash flow from operations
Evaluating In Veritas' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate In Veritas' stock performance include:
  • Analyzing In Veritas' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether In Veritas' stock is overvalued or undervalued compared to its peers.
  • Examining In Veritas' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating In Veritas' management team can have a significant impact on its success or failure. Reviewing the track record and experience of In Veritas' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of In Veritas' stock. These opinions can provide insight into In Veritas' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating In Veritas' stock performance is not an exact science, and many factors can impact In Veritas' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in IVME Stock

If you are still planning to invest in In Veritas Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the In Veritas' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets